EVTC vs GLOB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EVTC exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust ROE of 23.44%, yet it is trapped in a bearish technical trend. While the company maintains a low P/E of 13.41 and a very attractive forward P/E of 6.94, the current price of $29.51 trades at a significant premium to both its Graham Number ($22.32) and Intrinsic Value ($15.40). A critical divergence exists between revenue growth (+13.10%) and earnings growth (-9.90%), suggesting margin compression or rising operational costs. Overall, the stock is a fundamentally sound business currently lacking a catalyst for price appreciation.
Globant presents a classic 'value trap' profile: fundamentally undervalued but technically collapsing. The deterministic baseline shows a stable Piotroski F-Score of 4/9 and a current price ($42.40) trading below both the Graham Number ($49.61) and Intrinsic Value ($48.66). While the balance sheet is healthy with low debt (D/E 0.24), the company is facing a severe growth crisis with negative YoY and Q/Q revenue growth. The massive disconnect between the analyst target price ($70.13) and the 0/100 technical trend suggests a high-risk recovery play rather than a stable investment.
Compare Another Pair
Related Comparisons
EVTC vs GLOB: Head-to-Head Comparison
This page compares EVERTEC, Inc. (EVTC) and Globant S.A. (GLOB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.